Close Menu
SUBSCRIBE
A

Acitretin

Comprehensive Guide to Acitretin: Uses, Dosage, Side Effects, and More

What is Acitretin?

Acitretin is a systemic retinoid medication primarily prescribed for the treatment of severe psoriasis and various disorders of keratinization. Derived from vitamin A, Acitretin belongs to the second-generation retinoids and works by binding to retinoic acid receptors (RARs), which regulate cell differentiation, proliferation, and inflammation. This mechanism helps normalize the excessive skin cell turnover seen in psoriasis and other keratin-related conditions. Acitretin is distinguished by its oral administration, offering a non-immunosuppressive alternative to treatments like biologics, and its ability to induce long-term remission in some patients. Unlike its predecessor, etretinate, Acitretin has a shorter half-life, reducing but not eliminating the risk of teratogenicity, which remains a critical consideration. It is widely used globally, particularly in dermatology, due to its efficacy in managing chronic, debilitating skin conditions that do not respond to topical therapies or phototherapy.

Overview of Acitretin

Generic Name: Acitretin

Brand Name: Soriatane, Neotigason, among others

Drug Group: Acitretin is classified within the retinoid class, a group of compounds structurally related to vitamin A, known for their role in regulating epithelial cell growth and differentiation.

A box of Soriatane (Acitretin) 25 mg capsules by Arrow Génériques, showing French labeling with a prominent warning about mandatory contraception for women, used to treat severe psoriasis.
Soriatane (Acitretin) 25 mg capsules are an oral retinoid medication primarily used for the treatment of severe psoriasis and other keratinization disorders. A strict contraception regimen is required for women of childbearing potential due to its teratogenic effects.

Commonly Used For

Acitretin is employed to address a range of dermatological conditions, including:

  • Severe Psoriasis: Particularly effective for plaque, pustular, and erythrodermic psoriasis unresponsive to first-line treatments.
  • Keratinization Disorders: Includes congenital ichthyosis (e.g., lamellar ichthyosis) and keratosis follicularis (Darier’s disease), where abnormal skin scaling is prominent.
  • Other Skin Conditions: Occasionally used off-label for lichen planus, pityriasis rubra pilaris, and certain genodermatoses, showcasing its versatility.
  • Combination Therapy: Often paired with phototherapy (e.g., UVB) or methotrexate to enhance efficacy in resistant cases, though this requires careful monitoring.
This broad applicability makes Acitretin a cornerstone in managing severe cutaneous disorders, though its use is tailored to individual patient profiles and disease severity.

Indications and Uses of Acitretin

Approved Indications

Severe Psoriasis: Targets adults with psoriasis that is debilitating or resistant to topical corticosteroids, vitamin D analogs, or phototherapy. It is especially useful in erythrodermic and pustular forms, where systemic therapy is critical to prevent complications like infection or fluid loss.

Disorders of Keratinization: Approved for congenital ichthyosis (e.g., lamellar and X-linked forms) and Darier’s disease, conditions characterized by abnormal keratin production leading to scaling and skin fragility. Treatment aims to improve quality of life by reducing scaling and discomfort.

Psoriatic Arthritis: In some regions, it serves as an adjunct to manage joint symptoms alongside skin manifestations, though this is less common and often off-label.

Note: Regional differences exist; for instance, some countries may restrict its use to dermatologist supervision, and formulations (e.g., capsules) vary. Always consult local guidelines or a healthcare provider for precise indications.

Additional Uses

Beyond approved uses, Acitretin is employed off-label in:

Lichen Planus: Effective for severe, widespread cases or oral involvement, where it reduces inflammation and hyperkeratosis over weeks to months.

Pityriasis Rubra Pilaris: A rare disorder causing widespread scaling and redness, where Acitretin helps normalize skin turnover and alleviate symptoms.

Other Genodermatoses: Includes conditions like palmoplantar keratoderma, though evidence is anecdotal and requires specialist oversight.

Note: Off-label applications should be evidence-based and supervised by a dermatologist, considering the drug’s potent effects and potential risks.

Dosage of Acitretin

Important Note: Acitretin dosage must be individualized by a qualified healthcare provider, typically a dermatologist, due to its potency and side effect profile. Adherence to prescribed doses is crucial, as the dosage varies based on the condition, patient tolerance, and response over time.

Dosage for Adults

Psoriasis: Initial therapy often begins at 25 mg once daily with the main meal, titrated up to 50 mg/day based on tolerance and efficacy. Maintenance doses typically range from 25–50 mg/day, with a maximum of 75 mg/day for severe cases, though higher doses are rarely sustained due to toxicity risks.

Keratinization Disorders: Starts at 10 mg once daily, adjustable to 25 mg/day, depending on the extent of scaling and patient response. Doses are often lower due to chronic use requirements.

Maintenance Therapy: After achieving control (usually 2–3 months), doses are reduced to 10–25 mg/day to minimize side effects while maintaining remission.

Dosage for Children

Not Recommended: Acitretin is generally contraindicated in children under 18 due to limited safety data and potential effects on growth plates. Exceptions are made for severe ichthyosis under pediatric dermatologist supervision, with doses starting at 0.5 mg/kg/day, not exceeding 1 mg/kg/day.

Dosage for Pregnant Women

Acitretin is Category X and strictly contraindicated during pregnancy due to its teratogenic effects, which can cause severe birth defects (e.g., craniofacial, cardiovascular, and neural tube defects). Women of childbearing potential must use two forms of contraception and avoid pregnancy for at least 3 years post-treatment. Dosage is irrelevant in this population due to the contraindication.

Dosage Adjustments

Renal or Hepatic Impairment: Patients with compromised liver or kidney function require dose reduction (e.g., 10–25 mg/day) and frequent monitoring of liver enzymes and creatinine levels.

Administration: Take with a meal containing fat (e.g., dairy or oil) to enhance bioavailability, as absorption increases with dietary fat content.

Titration and Discontinuation: Gradual dose escalation is recommended to assess tolerance, and tapering is advised when discontinuing to prevent disease flare-ups.

Additional Considerations

  • Regular blood tests (e.g., liver function, lipid profile) are essential every 1–2 months during the first year.
  • Avoid exceeding recommended doses to prevent cumulative toxicity, especially in long-term therapy.

How to Use Acitretin

Instructions for Use

With Food: Administer with a meal or milk containing fat to optimize absorption, as Acitretin is lipophilic. A breakfast with butter, cheese, or oil is ideal.

Swallow Whole: Capsules must be swallowed intact to ensure controlled release; crushing or chewing can alter pharmacokinetics and increase side effects.

Timing: Take at a consistent time daily, preferably with the largest meal, to maintain steady blood levels and reduce gastrointestinal irritation.

What to Do If You Forget to Take a Dose

  • Take the missed dose with the next meal if remembered within the same day, but skip it if it’s close to the next scheduled dose to avoid doubling. Contact your doctor if unsure or if multiple doses are missed, as this may affect treatment efficacy.
  • Do not double the dose to compensate, as this increases the risk of toxicity.

Additional Tips

  • Use a pill organizer or set reminders to ensure adherence, especially given the long treatment duration.
  • Avoid taking with grapefruit juice, which may interfere with metabolism, though evidence is limited.

Contraindications for Acitretin

Acitretin is contraindicated in:

Hypersensitivity: Patients with known allergies to Acitretin, other retinoids (e.g., isotretinoin), or parabens (used as stabilizers in some formulations).

Pregnancy: Absolute contraindication due to Category X status and teratogenic risks, requiring strict pregnancy prevention protocols.

Severe Hepatic or Renal Impairment: Unsafe in patients with significant liver or kidney dysfunction, where drug clearance is compromised.

Concurrent Diseases: Avoid in conditions like hyperlipidemia or uncontrolled diabetes, which may worsen with retinoid therapy.

Warnings & Precautions for Acitretin

Use in Specific Populations

Pregnancy: Category X; teratogenicity includes malformations detectable within the first trimester. Women must undergo pregnancy testing before, during, and after treatment, with contraception mandated for 3 years post-therapy.

Breastfeeding: Contraindicated due to potential excretion in breast milk and unknown effects on infants.

Elderly: Higher susceptibility to hepatotoxicity and lipid abnormalities; require dose adjustments and frequent monitoring.

Children: Contraindicated except in rare, severe cases (e.g., ichthyosis) under specialist care, with growth and development closely watched.

Additional Precautions

  • Inform your doctor about a history of depression, liver disease, or pancreatitis, as Acitretin may exacerbate these conditions.
  • Regular ophthalmologic exams are recommended due to risks of night blindness or corneal opacities with prolonged use.

Overdose and Management of Acitretin

Overdose Symptoms

Acitretin overdose may manifest as:

  • Acute symptoms like headache, nausea, vomiting, and dizziness within hours of ingestion.
  • Chronic overexposure leading to increased intracranial pressure (pseudotumor cerebri), hepatotoxicity, or hyperlipidemia.
  • Severe cases may result in coma or irreversible liver damage, though rare with therapeutic doses.

Immediate Actions

Seek Medical Attention: Contact a healthcare provider or emergency services immediately if overdose is suspected.

Provide Details: Report the exact amount ingested, time of intake, and any co-ingested substances to guide treatment.

Treatment: No specific antidote exists; management includes gastric lavage (if recent), supportive care (e.g., IV fluids), and monitoring of liver function and intracranial pressure.

Additional Notes

  • Overdose risk is heightened with alcohol consumption or in patients with pre-existing liver conditions.
  • Secure storage is critical, especially in households with children or vulnerable individuals.

Side Effects of Acitretin

Common Side Effects

Skin and Mucous Membranes: Dryness of skin, lips (cheilitis), and eyes, often requiring emollients or artificial tears.

Hair: Thinning or alopecia, typically reversible upon discontinuation but distressing for some patients.

Systemic: Mild headache, fatigue, or muscle stiffness, often transient as the body adjusts.

Serious Side Effects

Seek immediate medical attention for:

Hepatotoxicity: Jaundice, dark urine, or right upper quadrant pain indicating liver injury.

Psychiatric Effects: Depression, anxiety, or suicidal ideation, requiring urgent psychiatric evaluation.

Ocular Toxicity: Blurred vision, night blindness, or corneal ulcers, necessitating ophthalmologic consultation.

Hyperlipidemia: Elevated triglycerides or cholesterol, increasing cardiovascular risk with long-term use.

Additional Notes

  • Side effects are dose-dependent and often diminish with dose reduction or continued use as tolerance develops.
  • Regular monitoring (e.g., monthly for the first 6 months) helps manage and mitigate severe outcomes.

Drug Interactions with Acitretin

Acitretin may interact with:

Alcohol: Significantly increases hepatotoxicity and hypertriglyceridemia risk, necessitating complete avoidance.

Tetracyclines: Combined use heightens intracranial pressure risk, mimicking pseudotumor cerebri.

Vitamin A: Excessive intake amplifies retinoid toxicity, leading to symptoms like headache and nausea.

Methotrexate: Synergistic liver damage potential requires careful monitoring of liver enzymes.

Action: Disclose all medications, including over-the-counter drugs and supplements, to your healthcare provider to prevent adverse interactions and adjust therapy as needed.

Patient Education or Lifestyle

  • Diet: Avoid alcohol entirely and limit vitamin A-rich foods (e.g., liver, carrots) to prevent toxicity. A balanced diet supports overall health during treatment.
  • Sun Protection: Use broad-spectrum SPF 30+ sunscreen, wear protective clothing, and avoid tanning beds due to heightened photosensitivity, which can exacerbate skin dryness.
  • Exercise: Engage in moderate activity unless joint pain or fatigue occurs; consult your doctor if side effects limit mobility.
  • Monitoring: Undergo regular blood tests (liver function, lipids) and eye exams; report mood changes, vision issues, or severe skin reactions promptly to your healthcare provider.

Pharmacokinetics of Acitretin

Absorption: Highly lipophilic, with absorption enhanced 2–3 times when taken with a fat-containing meal; peak plasma concentrations occur within 1–4 hours.

Bioavailability: Approximately 60–70%, varying with dietary fat intake and individual metabolism.

Metabolism: Undergoes extensive hepatic metabolism to active metabolites, including etretinate, which has a much longer half-life and contributes to teratogenic persistence.

Excretion: Primarily via bile and feces (50–60%), with minimal renal clearance; metabolites can be detected in the body for months.

Half-Life: Around 49 hours, but etretinate metabolites may persist for 2–3 years, necessitating prolonged contraception.

Pharmacodynamics of Acitretin

Acitretin exerts its effects by:

  • Binding to retinoic acid receptors (RAR-alpha, -beta, -gamma), altering gene expression to normalize keratinocyte proliferation and differentiation.
  • Reducing inflammation by downregulating pro-inflammatory cytokines (e.g., TNF-alpha, IL-6), which is key in psoriasis management.
  • Promoting long-term remission by restructuring epidermal architecture, though benefits may wane if discontinued abruptly.

Storage of Acitretin

Temperature and Recommendations

Capsules: Store at 15–25°C (59–77°F) in a dry environment, as humidity can degrade the active ingredient.

Protect from Light: Keep in the original amber container to shield from UV exposure, which may alter potency.

Avoid Freezing: Prevent storage in refrigerators or excessively cold areas to maintain stability.

Safety Notes

Keep Out of Reach of Children: Use a locked cabinet or high shelf, given the teratogenic risks and potential for accidental ingestion.

Dispose Properly: Follow local pharmaceutical disposal guidelines (e.g., take-back programs) or mix with undesirable substances (e.g., coffee grounds) before discarding to prevent misuse.

Additional Storage Tips

  • Check expiration dates regularly and discard if capsules appear discolored, cracked, or odorous.
  • Avoid transferring to non-original containers, as this may compromise child safety features.

Frequently Asked Questions (FAQs)

Q: Can I take Acitretin with food?
A: Yes, take with a meal containing fat (e.g., dairy or oil) to improve absorption and reduce stomach upset.

Q: Is Acitretin safe for children?
A: No, it’s generally contraindicated unless prescribed by a specialist for severe ichthyosis, with strict monitoring.

Q: Can Acitretin cause hair loss?
A: Yes, temporary hair thinning is common; it often reverses after stopping, but consult your doctor if severe.

Q: Does Acitretin interact with alcohol?
A: Yes, alcohol significantly increases liver and lipid risks; complete avoidance is recommended.

Q: How long does Acitretin take to work?
A: Noticeable improvement in psoriasis may start within 2–4 weeks, with optimal results typically seen after 2–3 months of consistent use.

Regulatory Information

Acitretin is approved and regulated by major international agencies, including:

U.S. Food and Drug Administration (FDA): Approved specifically for severe psoriasis, with strict pregnancy prevention protocols.

European Medicines Agency (EMA): Authorized for psoriasis and keratinization disorders, with similar safety restrictions across the EU.

Other Agencies: Regulatory bodies in Asia, Africa, and Latin America approve Acitretin for dermatological use, often under dermatologist oversight.

Consult local guidelines or a healthcare provider for region-specific prescribing practices and availability.

Disclaimer: This article is intended for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Acitretin is a prescription medication with potentially serious side effects and should only be used under the supervision of a qualified healthcare provider. Always consult your doctor or pharmacist before starting, stopping, or changing any medication.

References

  1. Soriatane (Acitretin) Prescribing Information – U.S. Food and Drug Administration (FDA), 2023.
    • Official FDA documentation providing detailed Acitretin prescribing guidelines, safety data, and teratogenicity warnings for the USA.
  2. Acitretin Summary of Product Characteristics – European Medicines Agency (EMA), 2023.
    • EMA’s comprehensive resource on Acitretin’s indications, dosage, and precautions for use in the European Union.
  3. Acitretin: MedlinePlus Drug Information – National Institutes of Health (NIH), 2023.
    • NIH’s authoritative guide offering in-depth information on Acitretin’s uses, side effects, and patient counseling for a global audience.
  4. WHO Model List of Essential Medicines: Acitretin – World Health Organization (WHO), 2023.
    • WHO’s recognition of Acitretin as an essential medicine for severe psoriasis management worldwide.
  5. Acitretin in Psoriasis Management – New England Journal of Medicine, 2022.
    • Peer-reviewed study evaluating Acitretin’s long-term efficacy and safety in psoriasis, accessible with subscription (https://www.nejm.org).

Dr. Andrew Parker is a board-certified internal medicine physician with over 10 years of clinical experience. He earned his medical degree from the University of California, San Francisco (UCSF), and has worked at leading hospitals including St. Mary’s Medical Center. Dr. Parker specializes in patient education and digital health communication. He now focuses on creating clear, accessible, and evidence-based medical content for the public.

Related Posts